Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis

Back

ESC Premium Access

Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis

Session: Atrial fibrillation - General 2

Topic: Cardioversion and Defibrillation

Speaker: Doctor W. McIntyre (Hamilton, CA)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor William McIntyre

Population Health Research Institute, Hamilton (Canada)

3 presentations

0 follower

6 more presentations in this session

Four targeted therapies and less than four targeted therapies of underlying conditions against conventional therapy in atrial fibrillation - data from the RACE 3 study

Speaker: Miss B. Nguyen (Groningen, NL)

Access

Abstract

Slides

SGLT 2 inhibitor suppresses atrial fibrillation in the canine model of atrial fibrillation.

Speaker: Doctor R. Nishinarita (Tokyo, JP)

Access

Abstract

Slides

Association of left atrial size with ischemic and bleeding risk scores in patients with non-valvular atrial fibrillation

Speaker: Doctor L. Enriquez Rodriguez (Soria, ES)

Access

Abstract

Slides

How could non-vitamin k antagonist oral anticoagulants change clinical practice for stroke prevention and improve outcomes in patients with newly-diagnosed atrial fibrillation?

Speaker: Doctor T. Chao (Taipei, TW)

Access

Abstract

High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI

Speaker: Doctor R. De Caterina (Pisa, IT)

Access

Abstract

Slides

Access the full session

Atrial fibrillation - General 2

Speakers: Doctor W. McIntyre, Miss B. Nguyen, Doctor R. Nishinarita, Doctor L. Enriquez Rodriguez, Doctor T. Chao...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources